|
gptkbp:instanceOf
|
gptkb:recreational_drug
gptkb:chemical_compound
gptkb:NMDA_receptor_antagonist
gptkb:dissociative_drug
|
|
gptkbp:boilingPoint
|
136-137°C (at 0.5 mmHg)
|
|
gptkbp:CASNumber
|
77-10-1
|
|
gptkbp:chemicalFormula
|
C17H25N
|
|
gptkbp:detects
|
urine drug test
|
|
gptkbp:developedBy
|
gptkb:Parke-Davis
|
|
gptkbp:developedInYear
|
1956
|
|
gptkbp:effect
|
gptkb:center
hypertension
numbness
dissociation
tachycardia
euphoria
hallucinations
agitation
analgesia
delusions
seizures (in overdose)
|
|
gptkbp:eliminationHalfLife
|
7-46 hours
|
|
gptkbp:excretion
|
urine
|
|
gptkbp:hasStreet
|
ozone
rocket fuel
angel dust
embalming fluid
supergrass
wack
|
|
gptkbp:isAbusedAs
|
gptkb:recreational_drug
|
|
gptkbp:isPrecursorFor
|
gptkb:ketamine
|
|
gptkbp:isProhibitedIn
|
most countries
|
|
gptkbp:IUPACName
|
1-(1-phenylcyclohexyl)piperidine
|
|
gptkbp:legalStatus
|
Class A drug (UK)
Schedule II controlled substance (US)
Schedule I controlled substance (Canada)
|
|
gptkbp:meltingPoint
|
46-47°C
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:molecularWeight
|
243.39 g/mol
|
|
gptkbp:riskFactor
|
addiction
psychosis
neurotoxicity
violent behavior
|
|
gptkbp:routeOfAdministration
|
smoking
oral
inhalation
intravenous
|
|
gptkbp:synonym
|
gptkb:PCP
angel dust
|
|
gptkbp:usedAs
|
anesthetic (historical)
|
|
gptkbp:bfsParent
|
gptkb:dextromethorphan
|
|
gptkbp:bfsLayer
|
6
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
phencyclidine
|